S. Simion *, F Ticmeanu *, Al. Marcov **, R. Macovei ***, Ioana Simion **, B. Mastalier *, C. Popa *
* S. Simion, R Ticmeanu, B. Mastalier, C. Popa – Clinica de chirurgie “N. Ch. Lupu”, București
** Al. Marcov, Ioana Simion – Secția A.T.I. Spitalul “N. Ch. Lupu”, București
*** R. Macovei – Secția Toxicologie Spitalul de Urgență Floreasca, București
Abstract
In our concerns for using the newest pharmaceutical products, we performed this study in patients with thromboembolic risk that have undergone a surgical intervention in our clinic, by administrating low – molecular weight heparin (Clexane-enoxaparin, Fraxiparine, Clivarin and Fragmin).